| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |